Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Fall on the Road
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2023 Readersâ Choice Winners
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about SRPT
Recent news which mentions SRPT
< Previous
1
2
3
4
5
6
7
8
9
Next >
Does This 1 New Threat Make Sarepta Therapeutics Stock Worth Selling?
March 13, 2024
Tickers
RGNX
SRPT
Tags
Market News
SRPT
Recent Press Releases
From
Motley Fool
This Gene Therapy Player Duchenne Data Is Impressive, Analyst Upgrades REGENXBIO
March 08, 2024
Tickers
NEWS
PFE
RGNX
SRPT
Tags
Analyst Ratings
Market News
PFE
From
Benzinga
Got $1,000? Buy These Hot Growth Stocks Before They Take Off.
March 08, 2024
Tickers
ENPH
GOOG
GOOGL
SRPT
Tags
SRPT
Market News
ENPH
From
Motley Fool
Sarepta Therapeutics Stock Has 73% Upside, According to 1 Wall Street Analyst
March 04, 2024
Tickers
SRPT
Tags
Recent Press Releases
SRPT
Market News
From
Motley Fool
Sarepta Therapeutics (SRPT) Q4 2023 Earnings Call Transcript
February 29, 2024
Tickers
SRPT
Tags
Recent Press Releases
SRPT
Market News
From
Motley Fool
Sarepta Therapeutics: Q4 Earnings Insights
February 28, 2024
Tickers
SRPT
Tags
Market News
Earnings
BZI/Recaps
From
Benzinga
Is It Too Late to Buy Sarepta Therapeutics Stock?
February 28, 2024
Tickers
SRPT
Tags
Recent Press Releases
SRPT
Market News
From
Motley Fool
Earnings Scheduled For February 28, 2024
February 28, 2024
Tickers
NOVT
NRG
NSA
NTNX
Tags
RXST
WHD
OKTA
From
Benzinga
A Preview Of Sarepta Therapeutics's Earnings
February 27, 2024
Tickers
SRPT
Tags
Earnings
Market News
SRPT
From
Benzinga
Median Drug Prices For Rare Diseases Hit $300K In 2023, Report Highlights Lack of Clear Rationale Behind Escalating Drug Prices
February 26, 2024
Tickers
CRSP
NEWS
REGN
SRPT
Tags
Markets
Stories That Matter
General
From
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
February 19, 2024
Tickers
ARQT
IOVA
LLY
MDT
Tags
ARQT
MDT
MRNA
From
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 19, 2024
Tickers
AMIX
AMN
AORT
BCLI
Tags
AMIX
Benzinga
AMN
From
Benzinga
FDA Fast-Tracks Review Of Sarepta's Groundbreaking Muscular Dystrophy Treatment With $1B Market In Sight
February 16, 2024
Tickers
NEWS
RHHBY
SRPT
Tags
Health Care
SRPT
Biotech
From
Benzinga
Why DoorDash Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 16, 2024
Tickers
AMAT
AMBO
AMN
AORT
Tags
CVNA
Trading Ideas
YELP
From
Benzinga
Why Sarepta Therapeutics Stock Is Soaring Today
February 16, 2024
Tickers
SRPT
Tags
Market News
SRPT
Recent Press Releases
From
Motley Fool
Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday
February 16, 2024
Tickers
AMAT
AORT
BIO
BLZE
Tags
VMC
Intraday Update
TOST
From
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 16, 2024
Tickers
AMN
AORT
CDIO
HCTI
Tags
Market News
AMN
TTOO
From
Benzinga
In-Depth Examination Of 13 Analyst Recommendations For Sarepta Therapeutics
February 15, 2024
Tickers
SRPT
Tags
Analyst Ratings
Market News
SRPT
From
Benzinga
2 Magnificent Growth Stocks to Buy With $500
February 15, 2024
Tickers
SRPT
VEEV
Tags
Market News
SRPT
VEEV
From
Motley Fool
Gene Therapy Player REGENXBIO's RGX-121 Marks Success In Trial, Yet Faces Challenges In A Crowded Market: Analyst
February 12, 2024
Tickers
DNLI
NEWS
PFE
RGNX
Tags
Reiteration
RGNX
Analyst Color
From
Benzinga
1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock?
February 11, 2024
Tickers
PTCT
SRPT
Tags
PTCT
Recent Press Releases
Market News
From
Motley Fool
The Top 25 Stocks to Buy Immediately According to AI: February 2024 Edition
February 06, 2024
Tickers
ADP
AJG
AMGN
AMH
Tags
HAL
MA
AJG
From
InvestorPlace
Assessing Sarepta Therapeutics: Insights From 12 Financial Analysts
January 30, 2024
Tickers
SRPT
Tags
BZI/AAR
Benzinga
Analyst Ratings
From
Benzinga
Sarepta Therapeutics' Next-Gen Duchenne Muscular Therapy Shows Efficacy At Less Frequent Dosing
January 29, 2024
Tickers
NEWS
SRPT
Tags
Biotech
SRPT
Large Cap
From
Benzinga
Got $3,000? 3 Growth Stocks to Double Up On Right Now
January 26, 2024
Tickers
SRPT
SYM
UBER
Tags
SRPT
UBER
Market News
From
Motley Fool
Could Sarepta Therapeutics Become the Next Vertex Pharmaceuticals?
January 25, 2024
Tickers
SRPT
VRTX
Tags
VRTX
Recent Press Releases
Market News
From
Motley Fool
Why Sarepta Therapeutics Stock Zoomed Nearly 5% Higher Today
January 22, 2024
Tickers
JPM
SRPT
Tags
Market News
SRPT
JPM
From
Motley Fool
Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market
January 16, 2024
Tickers
ATOS
SRPT
UTHR
Tags
ATOS
NASDAQ:SRPT,NASDAQ:ATOS,NASDAQ:UTHR
SRPT
From
InvestorPlace
A Closer Look at 14 Analyst Recommendations For Sarepta Therapeutics
January 10, 2024
Tickers
SRPT
Tags
BZI/AAR
Benzinga
Market News
From
Benzinga
Stocks Flip To Losses, Nvidia Defies Gravity, Bitcoin Pauses For A Breather: What's Driving Markets Tuesday?
January 09, 2024
Tickers
AMD
BA
BITCOMP
DIA
Tags
Top Stories
bitcoin
XLE
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.